Business
Sanofi Posts Strong Earnings as Dupixent Demand Keeps Growing
Sanofi SA reported better-than-expected profit in the first quarter, boosted by strong demand for its blockbuster skin and asthma drug Dupixent.
Source link
Continue Reading